Trimedyne to Expand Laser Tests: Trimedyne Inc....
- Share via
Trimedyne to Expand Laser Tests: Trimedyne Inc. said it has received Food and Drug Administration clearance to expand clinical trials of a “cold” laser to clear coronary arteries. Trials of the excimer laser, which has so far been tested on fewer than 100 patients at three centers in Pennsylvania, Texas and Palm Springs, will now be expanded to 10 medical centers across the United States.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.